Neuroinflammation has been shown to exacerbate the onset and progression of Alzheimer’s disease, and preclinical models demonstrate multiple direct effects of GLP-1 on attenuating neuroinflammation in the context of models of Alzheimer’s disease [15]. The gene discussed is GCG; the disease is early-onset autosomal dominant Alzheimer disease.